We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$6.45B
Cap. Flow %
0.91%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.77%
2 Consumer Discretionary 1.94%
3 Technology 1.9%
4 Communication Services 1.42%
5 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MENV
11501
DELISTED
AdvisorShares North Square McKee ESG Core Bond ETF
MENV
$202K ﹤0.01%
+7,782
New +$202K
HR
11502
PUT
DELISTED
Healthcare Realty Trust Incorporated
HR
$202K ﹤0.01%
6,700
-4,900
-42% -$153K
ACET icon
11503
Adicet Bio
ACET
$84.8M
$201K ﹤0.01%
1,223
-4,170
-77% -$849K
DGT icon
11504
State Street SPDR Global Dow ETF
DGT
$630M
$201K ﹤0.01%
+1,815
New +$201K
DNTH icon
11505
Dianthus Therapeutics
DNTH
$6.21B
$201K ﹤0.01%
1,288
-397
-24% -$72.9K
GOSS icon
11506
CALL
Gossamer Bio
GOSS
$84.4M
$201K ﹤0.01%
24,700
-16,800
-40% -$146K
LSAK icon
11507
Lesaka Technologies
LSAK
$396M
$201K ﹤0.01%
42,748
-2,269
-5% -$11.8K
NNBR icon
11508
CALL
NN Inc
NNBR
$297M
$201K ﹤0.01%
27,300
-38,300
-58% -$288K
PRO
11509
DELISTED
PROS Holdings
PRO
$201K ﹤0.01%
+4,409
New +$195K
SXC icon
11510
PUT
SunCoke Energy
SXC
$845M
$201K ﹤0.01%
28,200
+16,200
+135% +$115K
TARA icon
11511
Protara Therapeutics
TARA
$232M
$201K ﹤0.01%
+20,609
New +$233K
UFI icon
11512
UNIFI
UFI
$139M
$201K ﹤0.01%
8,248
-2,680
-25% -$71.5K
FBMS
11513
DELISTED
The First Bancshares, Inc.
FBMS
$201K ﹤0.01%
+5,378
New +$207K
ASMB icon
11514
PUT
Assembly Biosciences
ASMB
$717M
$200K ﹤0.01%
4,292
-958
-18% -$47.5K
DES icon
11515
WisdomTree US SmallCap Dividend Fund
DES
$2.2B
$200K ﹤0.01%
6,286
-26,381
-81% -$853K
DAKT icon
11516
Daktronics
DAKT
$951M
$199K ﹤0.01%
30,167
-8,671
-22% -$56.6K
GDXD icon
11517
MicroSectors Gold Miners -3x Inverse Leveraged ETN
GDXD
$387M
$199K ﹤0.01%
5
PBYI icon
11518
CALL
Puma Biotechnology
PBYI
$472M
$199K ﹤0.01%
21,700
-14,300
-40% -$145K
CASA
11519
PUT
DELISTED
Casa Systems, Inc. Common Stock
CASA
$199K ﹤0.01%
22,400
-10,100
-31% -$89.6K
SNR
11520
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$199K ﹤0.01%
+22,653
New +$156K
CECO icon
11521
Ceco Environmental
CECO
$4.24B
$198K ﹤0.01%
27,585
+5,284
+24% +$40.9K
LCNB icon
11522
LCNB Corp
LCNB
$274M
$198K ﹤0.01%
+12,086
New +$212K
LIND icon
11523
Lindblad Expeditions
LIND
$2.02B
$198K ﹤0.01%
+12,360
New +$209K
LSTA icon
11524
PUT
Lisata Therapeutics
LSTA
$17.5M
$198K ﹤0.01%
8,200
+1,913
+30% +$45.3K
NFBK
11525
DELISTED
Northfield Bancorp
NFBK
$198K ﹤0.01%
12,049
+502
+4% +$8.27K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.